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Potato virus X (PVX) is a single-stranded RNA plant virus, historically investigated in light
of the detrimental effects on potato, the world’s fourth most important food commodity.
The study of the interactions with cells, and more generally with the plant, both locally
and systemically, significantly contributed to unveil the mechanisms underlying gene
silencing, fundamental not only in plant virology but also in the study of gene expression
regulation. Unraveling the molecular events of PVX infection paved the way for the
development of different viral expression vectors and consequential applications in
functional genomics and in the biosynthesis of heterologous proteins in plants. Apart
from that, the ease of manipulation and the knowledge of the virus structure (particle
dimensions, shape and physicochemical features) are inspiring novel applications, mainly
focused on nanobiotechnology. This review will lead the reader in this area, spanning
from fundamental to applied research, embracing fields from plant pathology to vaccine
and drug-targeted delivery, imaging and material sciences. Due to the versatile moods,
PVX holds promise to become an interesting nanomaterial, in view to create the widest
possible arsenal of new “bio-inspired” devices to face evolving issues in biomedicine and
beyond.
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INTRODUCTION TO POTATO VIRUS X MOLECULAR PATHOLOGY
Potato virus X (PVX) belongs to the genus Potexvirus of the Flexiviridae family that groups
viruses phylogenetically related by replication mechanisms, structural proteins and genome type
and organization (Martelli et al., 2007). PVX is mechanically transmitted and its main hosts are
herbaceous plants, especially Solanaceae. It has been included among the pathogens with important
economic impact and its effects can be worsened by co-infection with other viruses, in particular
Potato virus Y (PVY; a phenomenon also known as “synergism”; Syller, 2012).
Potato virus X has a simple filamentous flexible structure of about 500 nm in length and 15 nm in
diameter (Figure 1A). The virion has helical symmetry and a deeply grooved, highly hydrated surface
(Parker et al., 2002). It is made of a single-stranded positive-sense RNA genome of approximately
6.4 kb (Huisman et al., 1988; Skryabin et al., 1988), wrapped in approximately 1300 units of a single
coat protein (CP) type, with 8.9 CP units per helix turn (Kendall et al., 2008).
The genome is capped at the 50-end and poly-adenylated at the 30-terminus. It contains five open
reading frames (ORFs) encoding five proteins: the RNA-dependent RNA Polymerase (RdRP), the
movement proteins encoded by three overlapping ORFs that form the Triple Gene Block module
(TGBp1, TGBp2, and TGBp3), and the CP (Figure 1B; Sonenberg et al., 1978; Morozov et al., 1987,
1991). The majority of these proteins are multifunctional and involved in several different steps
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FIGURE 1 | (A) Transmission electron micrographs of purified PVX
nanoparticles (personal unpublished data). Bars: 100 nm. (B) Schematic
diagram of PVX genome, genomic and subgenomic RNAs (gRNA and
sgRNA, respectively), and the proteins they encode. RdRP: RNA-dependent
RNA Polymerase; TGBp1/p2/p3: Triple Gene Block proteins; CP: Coat
Protein. Arrows represent the subgenomic promoters. The 50 cap and the
polyA tail are indicated.
of the infection process, together with numerous host factors.
The RdRP, for example, contains a methyl transferase type 1
domain involved in viral RNAs capping (Rozanov et al., 1992), a
helicase domain fundamental for viral replication (Davenport and
Baulcombe, 1997), and a replicase domain (Longstaff et al., 1993);
while TGBp1 has RNA-binding, ATPase (Leshchiner et al., 2006)
and RNA-helicase (Kalinina et al., 2002) activities. Moreover,
TGBp1 contributes to: (a) increase the size exclusion limit of the
plasmodesmata (PD; Angell et al., 1996; Howard et al., 2004), (b)
translationally activate the progeny virions (Karpova et al., 2006),
and (c) counteract gene silencing (Voinnet et al., 2000), the plant
innate mechanism of immune resistance.
When PVX enters plant cells, the particles unpack thanks to
the phosphorylation events mediated by cellular enzymes on
Ser/Thr residues located at the solvent-exposed N-terminus
of the CP (Atabekov et al., 2001). The RdRP is directly
synthetized from the viral RNA genome, exploiting the host
translational machinery, to subsequently give rise to sub-
genomic RNAs and viral proteins (Batten et al., 2003). Later
on, within infected cells, the replication complexes become
part of structures called X-bodies that are formed next to the
nucleus (Tilsner et al., 2012). X-bodies are isolated environments
delimited by remodeled cellular membranes and organized
in “compartments” that incorporate both viral and host
components, coordinating the different phases of infection
(replication, protein synthesis, assembly, and movement).
The primary function of X-bodies is to protect and allow
viral replication through the anchoring of RdRP in arrays to
membranes, yet being sites where ribonucleoprotein (RNP)
complexes (involved in cell-to-cell transfer of infection) and
complete virus particles are assembled. TGBp1 has a central
role in the formation of X-bodies as it participates to the
remodeling of host actin filaments, endoplasmic reticulum
(ER) and Golgi membranes, and to the recruitment of the viral
TGBp2 and TGBp3. Within X-bodies, aggregates of TGBp1
and actin microfilaments wrap in spirals to form the typical
“beaded sheets,” electron microscopy-visible structures in PVX
infected cells (Linnik et al., 2013). The spirals are surrounded by
naked viral RNAs and fine membrane hoops/granular vesicles
that contain TGBp2, TGBp3, ribosomes, and viral replicase,
probably representing replication sites. The TGBp2 and TGBp3
membrane-spanning proteins contribute individually and/or
synergistically to the formation of these vesicles by remodeling
the ER membranes. At the periphery of X-bodies, assembled viral
particles accumulate.
In the initial/middle phases of the infection, TGBp2 and
TGBp3 exploit the dynamic ER/actin network to direct the
transfer of RNP complexes, made of viral RNA and CP, from
the perinuclear to the cortical ER (Tilsner et al., 2012). It has
been recently suggested that later on the TGBp2 and TGBp3
remodeled ER-membranes form caps of the PD orifice and that
these caps, harboring the RdRP and viral RNA, become the
viral replication sites. According to this “co-replication model,”
as soon as they are synthetized, RNP complexes are inserted by
the TGBp1 into the PD for cell-to-cell transfer (Tilsner et al.,
2013).
As for viral spread throughout the plant, the CP is necessary
both in cell-to-cell and in systemic movement, but recently
published data indicate that virus particle assembly is dispensable
for local while essential for long-distance transfer (Santa Cruz
et al., 1998; Betti et al., 2012). The CP has a pivotal role in virus
particle morphology and stability, and strongly influences the
efficiency of infection spreading (Lico et al., 2006). Unfortunately,
atomic-resolution data defining its folding are not available. A
recent revision of the protein model indicates that it contains
seven a-helices and six b-strands and confirms that the N-
terminus is exposed on the viral surface (Baratova et al., 2004;
Lukashina et al., 2009, 2012).
Potato virus X has been used as model to study plant-virus
interactions and to elucidate the plant-defense mechanisms and
viral countermeasures such as suppression of silencing (Ruiz et al.,
1998; Ratcliff et al., 1999). The plant is not a passive host during
viral infection and viral RNA sensing induces the activation of
defense responses that involve a complex set of proteins. The
post-transcriptional RNA gene-silencing (PTGS) is a homology-
dependent gene inactivation strategy that is triggered by the
unusual presence in the plant cell of double stranded (ds) RNAs
(Tenllado and Díaz-Ruíz, 2001). In the case of a viral infection,
the PTGS response is activated by highly structured regions
in the viral genomes or in the viral replication intermediates.
These abnormal RNA structures are digested by a plant cell
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dsRNA-specific RNase, named Dicer, into 21–24 nucleotides
RNA species (small interfering RNAs, siRNAs; Hamilton and
Baulcombe, 1999). The siRNAs are then exploited through a
sequence complementarity mechanism to recruit the homologous
RNA into an RNA-induced silencing complex (RISC), where it is
digested (Voinnet, 2005).
Also viral proteins contribute to trigger plant innate defense. In
particular, the CP has been shown to work as pathogen avirulence
effector of the Rx protein-mediated resistance (Bendahmane et al.,
1995). Folding of the Rx protein is modified by CP binding
and consequently nucleotide-binding site leucine-rich domains
are exposed thus determining the activation of the signaling
cascade and cell death (Moffett et al., 2002; Rairdan and Moffett,
2006).
Like other plant viruses, PVX has evolved mechanisms to
counteract plant innate defense through one of its multifunctional
protein, the TGBp1. The protein inhibits the formation of the
effector complexes involved in RNA silencing (Bayne et al., 2005)
by inducing, through the proteasome pathway, the degradation
of the Argonaute 1 nuclease, one of the RISC components (Chiu
et al., 2010).
Also the PVX-Potyviruses synergistic interaction that results
in the enhancement of pathogenicity of PVX in Nicotiana
benthamiana plants is somehow related to virus-induced gene
silencing through the involvement of the Potyviruses P1/Helper
component proteinase (HC-Pro; González-Jara et al., 2005;
Pacheco et al., 2012).
To bring over these fundamental studies aimed to clarify the
complex mechanisms underlying the plant-virus interaction, a
number of viral expression vectors have been developed (Lico
et al., 2008; Hefferon, 2012; Gleba et al., 2014; Peyret and
Lomonossoff, 2015). First generation viral expression vectors
usually harbor the cDNA form of the complete viral genome,
sometimes engineered to easily insert foreign sequences as
additional ORFs, or in substitution of a viral one, in association
to a strong promoter (Chapman et al., 1992). These vectors can
be directly used to infect the plant hosts, when the viral genome
is under the control of a plant specific promoter, or used as
template to generate in vitro an infectious transcript. In second-
generation vectors, viral components are separately inserted into
binary vectors and used to transform independently different
Agrobacterium cells. Bacterial cells are then mixed together and
used to co-infiltrate plant leaves (Gleba et al., 2014). Most of
these vectors have found application in different technological
fields.
In functional genomics studies, they are used to vehicle an
endogenous gene fragment, triggering the specific suppression
of the corresponding sequence in the genome (Ruiz et al., 1998;
Baulcombe, 1999). This reverse genetics technique known as
virus-induced gene silencing, is a high-throughput approach to
the analysis of plant gene functions.
In “molecular farming,” PVX-based vectors are currently being
used to vehicle and induce the expression in plants of foreign genes
encoding high added-value biomolecules (Komarova et al., 2010).
Last, but only in the order of appearance list, these vectors
appear extremely appealing also for nanotechnologies (Lico et al.,
2013), as described in the following paragraphs.
PVX NANOPARTICLES FOR SUBUNIT
VACCINE DELIVERY
Subunit vaccines are formulations based on isolated pathogens
components (proteins or peptides) that allow the activation of
highly specific and protective immune responses. Nowadays,
these vaccines are typically produced by recombinant DNA
technologies. Compared to traditional inactivated or attenuated
vaccines, subunit vaccines guarantee selectivity, specificity, low
toxicity, stability and reduced risk of undesired side effects
(Rappuoli, 2007). Main limitation of these vaccines is that isolated
proteins or peptides being small (<10 nm) are per se unable
to stimulate complete immune responses (innate, antibody, and
cell-mediated). Indeed, it has been established that the efficiency
of antigen uptake by antigen presenting cells (APCs) is strictly
related to antigen sizes, and the larger surfaces of particulate
antigens improve the interaction with APCs (Bachman and
Jennings, 2010). To increase subunit vaccine immunogenicity, it
is thus important to arrange isolated antigens in larger particles
(20–200 nm). This is possible by entrapping them with adjuvants
or by favoring self-assembly in supramolecular structures, such as
in the case of virus-like particles generated by the self-assembly of
viral capsid proteins (Rosenthal et al., 2014). A further possibility
consists in delivering the antigen in association to nanoparticles,
such as liposomes.
Many attempts have also been made to increase subunit
vaccines immunogenicity and stability using genetically
engineered plant virus nanoparticles as carriers for their
delivery (Lico et al., 2007, 2013; Lebel et al., 2015; Streatfield et al.,
2015). As for PVX, this provides for the fusion of the sequence
encoding the immunogenic peptides or proteins in frame to the
50-end of the gene encoding the CP in viral expression vectors.
The N-terminus of the protein has indeed been demonstrated
to be exposed on the external surface of the virion (Baratova
et al., 1992). The modified viral expression vectors are then used
to induce infection onset in plants and produce on large scale
chimeric virus particles (CVPs) displaying on each CP subunit
(approx. 1300 per virion) the (poly)peptide of interest (Figure 2).
CVPs are then extracted from plant tissues and purified to be
used in immunization trials.
Because the CP is involved in mediating the interaction with
the plant environment, substantial modifications are not always
tolerated in that they may interfere with both viral encapsidation
and/or spread. These issues have been narrowly explored in
the past years and some basic rules have been defined, whose
compliance increases the chance of getting genetically stable
infectious CVPs. Clearly, the shorter the exogenous (poly)peptide,
the higher the probability that CP folding is preserved and
compatible with efficient assembly. But length is not the unique
parameter to be considered. Studies performed by fusing peptides
(variable in length and amino acid composition) to aN-terminally
truncated CP (a natural PVX mutant lacking the first 21 amino
acids) have indicated that also isoelectric point, Ser/Thr and Trp
content in the heterologous sequence may affect viral fitness (Lico
et al., 2006). Recently, the insertion of a heterologous sequence
between amino acids 23 and 24 at the N-terminus of the CP
has also been reported (Vaculik et al., 2015). Nonetheless, up
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FIGURE 2 | Schematic representation of a PVX nanoparticle, showing
the viral RNA (vRNA) and the shell composition of: a wild-type virion; a
chimeric virus particle exposing on every single CP unit (in gray) a
copy of the heterologous (poly)peptide (in yellow); a partially chimeric
virus particle in which only some of the CP units are fused to an entire
protein (in orange) through the OVERCOAT® procedure. In green the
FMDV 2A peptide.
to now no CP domains other than the N-terminus have been
identified that can harbor fusion peptides/proteins. Notably, the
fusion to the C-terminus does not give rise to CVPs able to
move throughout the plant (Cerovska et al., 2012). In fact, the C-
terminus of the protein is crucial for the interaction with the viral
RNA, hence for virion assembly (Nemykh et al., 2008).
On these bases, PVX particles displaying peptides of
immunological relevance have been successfully produced
in plants and their efficacy verified in animal models. PVX CVPs
displaying the linear 2F5 epitope (2F5e) of the gp41 protein
of Human Immunodeficiency Virus type 1 (HIV-1) envelope
are able to induce the production of epitope-specific IgA and
IgG, when administered intranasally or intraperitoneally in
normal mice without the need to co-administer adjuvants.
Notably, human dendritic cells pulsed with these CVPs are able
to activate a 2F5e-specific human primary antibody response in
severe combined immunodeficient mice engrafted with human
lymphocytes. Finally, the antibodies induced by immunization
with the CVPs are able to neutralize HIV-1 particles in viral
neutralization assays (Marusic et al., 2001).
Potato virus X CVPs displaying a Major Histocompatibility
Complex class I-restricted peptide of the nucleoprotein of
influenza virus have also been engineered, taking into account
mechanisms and limitations imposed by both plant virus biology
and immune response. The synthetic DNA fragment encoding the
influenza peptide was designed to be translated in an amino acid
sequence optimized to: (i) obtain assembly of CVPs able to move
systemically; (ii) minimize the risk of occurrence of unexpected
mutations during viral replication; (iii) avoid detrimental effects
of N-terminal modifications (such as acetylation) and improper
C-terminal context on peptide processing by APCs. These
rationally designed CVPs resulted to be genetically stable and
triggered epitope-specific CD8+ T cells without the need of
adjuvant co-delivery (Lico et al., 2009).
Overall, these data indicate that appropriately designed
PVX CVPs are excellent epitope carriers endowed of adjuvant
properties, probably not only because of the complex particulate
structure but also because of the presence of the viral RNA
that may trigger Toll-Like Receptor 7 on APCs (Jobsri et al.,
2015). Altogether, these features account for the inherent ability
of PVX to trigger a whole immune response, ideal condition
to achieve complete protection from pathogens through
vaccination.
Because one of the factors that may limit the construction of
PVX CVPs is the length of the fused (poly)peptide, a “smart”
procedure based on the OVERCOAT® PVX vector has also
been devised to avoid possible steric hindrance of chimeric
CPs during particle assembly (Santa Cruz et al., 1996). To
this aim, a 16 amino acid linker peptide (2A) derived from
the Foot and Mouth Disease Virus (FMDV) has been inserted
between the foreign sequence and the CP. During translation,
this sequence may induce a ribosomal skip with a frequency
that is dependent on the nature of the 18–30 amino acids in the
region immediately upstream the 2A cleavage site (Minskaia and
Ryan, 2013; Minskaia et al., 2013). The incomplete FMDV 2A-
mediated “cleavage” results in the production of a heterogeneous
population of CPs including original and engineered version, both
contributing to the assembly of fully functional CVPs able to
spread throughout the plant (Figure 2). By this strategy, PVX
particles were constructed displaying on the surface different
(poly)peptides of immunological interest. In the case of the
rotavirus major inner capsid protein (VP6; O’Brien et al., 2000)
and the tuberculosis ESAT-6 antigen (Zelada et al., 2006), data
demonstrated only the structural stability of the CVPs and the
correct display of the foreign sequences. Subsequent papers
demonstrated also the ability of these PVX CVPs to induce
antibody responses in animal models (rabbits and mice). This
is the case of the CVPs tailored to display the D2 peptide from
Staphylococcus aureus fibronectin-binding protein (Brennan et al.,
1999), two peptides from the E2 glycoprotein of the classical swine
fever virus (Marconi et al., 2006) or the R9 peptide from the
hypervariable region I of hepatitis C virus (Uhde-Holzem et al.,
2010).
Alternative approaches to the construction of PVX CVPs, even
if at higher costs, imply standard chemical protein conjugation
procedures. In this case, the success depends on the presence
of free amine groups (Lys residues) and carboxylate groups
(Asp and Glu residues). These amino acids are all present in
PVX CP. Different bioconjugation protocols have been tested
to functionalize PVX, revealing that the carboxylates groups are
either not solvent-exposed or not accessible. On the other hand,
N-Hydroxysuccinimide (NHS)-ester based and Cu(I)-catalyzed
azide-alkyne 1,3-dipolar cycloaddition (“CLICK”) reactions on
amine groups are both feasible (Steinmetz et al., 2010).
Potato virus X particles displaying a peptide derived from
the extracellular domain of the Human epidermal growth factor
receptor 2 (HER2) have been constructed by conjugation to
Lys on the CP surface through a two-step reaction via a
heterofunctional NHS-(poly)ethyleneglycole (PEG)4-maleimide
linker (Shukla et al., 2014a). HER2 is an antigen usually expressed
on breast cancer cells and known to induce the activation
of B lymphocytes and antibody production. The chemically
derivatized PVXparticleswere tested inmice and demonstrated to
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be effective in inducing the overcoming of HER2 immunological
tolerance by Enzyme Linked ImmunoSorbent Assay and confocal
microscopy using HER2-positive human cancer cells.
PVX NANOPARTICLES FOR IMAGING,
DRUG DELIVERY, AND DIAGNOSIS
Pioneering works in vaccine technology exploiting plant viruses
such as PVX have worked as trailblazer in the field of
nanotechnology. Indeed, the encouraging results prompted
scientists in nanomedicine to broaden the exploration and
exploitation of PVX particles as tools for targeted drug delivery
or for diagnosis. In this perspective, the evaluation of the
“biocompatibility” of viral particles, their natural tropism and
biodistribution are fundamental to enter clinical trials. Indeed,
the intrinsic toxicity cannot be taken for granted even if, for the
animal cell, plant viruses are expected to behave as unreplicative
and biologically safe nano-objects.
In vitro and in vivo experiments have been recently carried out
to evaluate the toxicity and teratogenicity potential of unmodified
PVX and Tomato Bushy Stunt Virus (TBSV), the type member of
another viral genus and family, different in shape and dimensions
(Blandino et al., 2015). Haemolysis assay was performed in vitro
to determine detrimental effect of virus nanoparticles on human
erythrocytes while toxicity and teratogenicity were evaluated in
vivo through the early embryo assay (EEA). Chicken embryo is
considered an excellent model to perform this kind of studies
even if the reliability of the results depends on critical factors
such as the choice of adequate controls, number of eggs per dose,
and volume and route of delivery. Overall, the results of this
study demonstrated that both plant viruses have neither cytotoxic
effects on human erythrocytes nor toxic/teratogenic effects on
chicken embryos. These data represent a good prerequisite for
safety evaluation in view of forthcoming use of these nanoparticles
as functionalized nanocarriers.
Biodistribution studies in vivo have been performed with PVX
particles conjugated to various fluorescent dyes and to PEG with
different chain lengths. PEG is frequently used to create a shield
around biopharmaceuticals to increase solubility and stability and
reduce immunogenicity even if, as a side effect, this masking
reduces the interactionswith cells, such as in the case of someplant
virus nanoparticles (Raja et al., 2003; Schlick et al., 2005; Steinmetz
and Manchester, 2009).
Preliminary studies in vitro, with human cervical cancer (HeLa)
cells and murine fibroblasts (BalbCl7), highlight somewhat
contradictory effects of PEGylation on PVX. In fact, this
procedure effectively prevents interaction with cells of particles
labeled with OregonGreen 488 (O488), while it promotes
interaction if particles are labeled with Alexafluor 647 (A647;
Steinmetz et al., 2010), and this is probably due to some intrinsic
feature of the dye.
The analysis of the biodistribution and clearance of A647-
labeled and PEGylated PVX in mice evidences that the viral
nanoparticles remain mainly trapped by the mononuclear
phagocyte system (MPS) that speeds up their removal from the
circulation and from tissues. Nonetheless, the flexible filamentous
PVX has enhanced tumor homing and tissue penetration, as
compared to the icosahedral Cowpea Mosaic virus (Shukla
et al., 2013, 2014b). Similarly, PVX CVPs constructed by the
OVERCOAT® procedure and carrying the mCherry fluorescent
protein but not conjugated to PEG, were shown to accumulate in
the liver and to co-localize with macrophages for final clearance
from tissues via MPS, 7 days post-administration in mice (Shukla
et al., 2014c). It has been recently shown that it is possible to
significantly improve PVX half-life in the serum reducing tissue
accumulation, renal clearance as well as uptake by immune cells
through derivatization of the viral surface with a PEG chain
tailored in length and conformation (brush vs. mushroom; Lee
et al., 2015).
Beside these early studies aimed to gain insights on PVX
nanoparticles-based delivery, advanced studies have already
started to exploit the virus as scaffold for the conjugation
of chemical moieties, constructing nano-bullets for molecular
imaging and targeted drug delivery.
A647-labeled PVX nanoparticles, bioconjugated with a 12
amino acid peptide with affinity to the epidermal growth factor
receptor (EGFR), are effective in detection and imaging of
carcinoma cell lines that upregulate EGFR, and prefer partitioning
to cancer cells rather than to macrophages (Chariou et al.,
2015). Furthermore, PVX particles conjugated to the Herceptin
(Trastuzumab) monoclonal antibody specific for the peptide
HER2 have been demonstrated to be able to induce the apoptosis
of HER2 positive cell lines (Esfandiari et al., 2015).
OTHER PVX NANOPARTICLES
APPLICATIONS
Genetically or chemically modified PVX nanoparticles can be
usefully applied also in fields other than vaccine and drug delivery
or in vivo imaging.
A diagnostic kit for the early detection of the Sjogren’s
Syndrome (SjS) has been recently developed (patent application
No. 102015000020005 Italian Patent Office), based on PVX CVPs
displaying a SjS diagnostic peptide. It has indeed been observed
that serum antibodies recognize much less efficiently this soluble
peptide if compared to the same peptide displayed on the viral
scaffold so that the sensitivity of the assay is noticeably increased,
preserving the specificity.
Potato virus X CVPs, displaying an antimicrobial decapeptide
derived from an anti-idiotypic antibody that acts as a functional
internal image of amicrobicidal broad-spectrumyeast killer toxin,
were active against Staphylococcus aureus and Candida albicans,
as well as against the plant pathogens Erwinia carotovora, Botrytis
cinerea, and Fusarium oxysporum. Moreover, they effectively
protected plants from Pseudomonas syringae attacks (Donini et al.,
2005).
Potato virus X CVPs carrying CPs fused to a single chain
antibody specific to Diuron herbicide were purified from plant
extracts by Diuron-based immune-capture, demonstrating their
potential as tools for in situ applications including remediation of
contaminated soils and waterways (Smolenska et al., 1998).
The fusion of GFP or mCherry protein to the PVX CP through
the 2A peptide strategy allowed to follow infection progression
throughout the plant, providing a non-invasive tool to the study
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of viral multiplication and spread (Santa Cruz et al., 1996, 1998;
Roberts et al., 1997; Tilsner et al., 2013; Shukla et al., 2014c).
Potato virus X provides also opportunities for nanochemistry
applications such as the construction of catalytic systems
operating like metabolons in nature. A proof of concept has
been published, in which the CVPs were constructed through
the OVERCOAT® system to display Lipase B, an enzyme derived
from Candida antarctica known to be an efficient enantiospecific
catalyst for chemical hydrolysis. The virus-anchored lipase
molecules retained their catalytic activity toward the substrate
p-nitrophenyl caproate in solution (Carette et al., 2007). Unlike
manmade supported catalysts, these PVX-based biocatalysts were
easily produced using plant machinery and, because the virus
particle is made of many proteins, they intrinsically possessed
multiple catalytic sites.
Recently, PVX nanoparticles have also been investigated as
scaffold for the attachment ofmetal atoms in an attempt to develop
new bioinorganic materials for nanoelectronics. Platinum atom
clusters (Pt nanoparticles, Pt-NPs) were built selectively at one
end of the virus helical structure by chemical reduction, yielding
virions that resemble a push-pin with a platinum head and a virus
needle (Drygin et al., 2013). These results highlight the specificity
of the coordinate metal interaction with a complex polyvalent
biological structure, thus providing insights on the mechanisms
of Pt-NPs formation, important to understand the interaction of
viral particles with ionic metals. Chimeric PVX particles have also
been constructed displaying multiple copies of a peptide that is
known to induce the formation of SiO2. By the conditions adopted
for synthesis, isolated SiO2 spots of about 10 nm were formed
along the surface of the chimeric virus. The not uniform SiO2
coating allowed additional immunogold labeling of the particles.
The possibility to combine silicification with immunolabeling
provides a method to develop triple-hybrid complex structures,
with controllable composition and functional properties (VanRijn
et al., 2015).
CONCLUSION
Overall, the knowledge of PVX, type-member of the Potexvirus
genus, has evolved from basicmolecular pathology to applications
in biomedicine and material science.
The knowledge of plant-pathogen interactions and related
silencing mechanisms has opened the way to the development
of novel genetically-controlled strategies of plant infection, and
through these to functional genomics and molecular farming.
By virtue of the innate versatility, PVX is now in the spotlight
as a promising nanoobject for applications in vaccinology, drug
targeting and delivery, diagnostic kits development and also as
imaging reporter tool.
Last but not least, it is investigated as scaffold for enzymatic
reactions or nanoelectronics.
For a long time, other plant viruses, mainly spherical or
rigid rod-shaped, have been preferred to PVX for this kind of
applications, but the data reviewed here clearly demonstrate that
the flexuous mood of this nanoparticle is not a constraint rather
a positive trait to be adequately exploited to respond to specific
needs. Although many of the illustrated applications are still in
their infancy, there is no reason to suppose they will not progress
rapidly.
The shift of PVX from foe to friend has been made
possible because this virus has been largely investigated in
its innermost mechanisms. This cultural trail clearly witnesses
how basic research can trigger a virtuous cycle of knowledge,
removing existing interdisciplinary boundaries and opening
up unimagined prospects, thus fuelling the development of
innovative technologies.
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